Attitudes toward genetic testing in patients with colorectal cancer

Cancer Practice

Volumn 8, Issue 4, 2000, Pages 178-186

  Kinney, Anita Yeomans ^a   Choi, Yeon Ah ^a   DeVellis, Brenda ^b   Millikan, Robert ^c   Kobetz, Erin ^b   Sandler, Robert S ^d  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer genetics; Colorectal carcinoma; Genetic counseling; Genetic testing; Hereditary cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; COLORECTAL CANCER; DECISION MAKING; FAMILIAL CANCER; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; UNITED STATES;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORTH CAROLINA; PATIENT EDUCATION; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK FACTORS;

EID: 0033914807     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.2000.84008.x     Document Type: Article

References (46)

1. American Cancer Society: Cancer Facts and Figures-2000, Atlanta, American Cancer Society; 2000.
2. Gryfe R, Swallow C, Bapat B, et al. Molecular biology of colorectal cancer. Curr Probl Cancer. 1997;21:233-300.
3. Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med. 1995;46:371-379.
4. Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: indications and procedures. Am J Gastroenterol. 1999;94:2344-2356.
5. Burt RW. Cohorts with familial disposition for colon cancers in chemoprevention trials. J Cell Biochem Suppl. 1996;S25: 131-135.
6. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah Population Database. J Natl Cancer Inst. 1994;86:1618-1626.
7. Giardiello FM. Genetic testing in hereditary colorectal cancer. JAMA. 1997;278:1278-1281.
8. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997;113:1146-1158.
9. Petersen GM, Brensinger JD, Johnson KA, Giardiello FM. Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer. 1999;S86:1720-1730.
10. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997;17:79-83.
11. Geller G, Bernhardt BA, Doksum T, et al. Decision-making about breast cancer susceptibility testing: How similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol. 1998;16:2868-2876.
12. Bernhardt BA, Geller G, Doksum T, Metz SA. Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing. Oncol Nursing Forum 2000;27:33-39.
13. Collins FS. Shattuck lecture - medical and societal consequences of the Human Genome Project. N Engl J Med. 1999; 341:28-37.
14. Hager M, (ed.): The Implications of Genetics for Health Professional Education., New York, Josiah Macy, Jr. Foundation; 1999.
15. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health. 1995;85:1435-1438.
16. Petersen GM, Larkin E, Codori AM, et al. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev. 1999;8: 337-344.
17. Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev. 1999;329-336.
18. Vernon SW, Gritz ER, Peterson SK, et al. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:353-360.
19. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med. 1993;22:284-292.
20. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12:843-850.
21. Lerman C, Trock B, Rimer BK, et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991;114:657-661.
22. Bluman LG, Rimer BK, Berry DA, et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol. 1999;17:1040-1046.
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
24. Hosmer DW, Lemeshow S: Applied Logistic Regression, New York, John Wiley & Sons; 1989.
25. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129: 125-137.
26. SPSS Inc.: SPSS 8.0, Chicago, Illinois, 1998.
27. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods., New York, John Wiley & Sons; 1987.
28. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer. 1996; 69:58-61.
29. Lerman C, Hughes C, Trock BJ, et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA. 1999;281: 1618-1622.
30. Geller G, Doksum T, Bernhardt BA, Metz SA. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiol Biomarkers Prev. 1999;8: 377-383.
31. Lerman C, Schwartz MD, Lin TH, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997;65:414-420.
32. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996;275: 1885-1892.
33. Codori AM, Petersen GM, Miglioretti DL, et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev. 1999;8:345-351.
34. Craufurd D, Dodge A, Kerzil-Storrar L, Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 1989;2:603-605.
35. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Amer J Med Genet. 1994;54: 167-173.
36. Gritz ER, Vernon SW, Peterson SK, et al. Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer. Cancer Res Ther Control. 1999;8:35-50.
37. Lea DH, Jenkins JF, Francomano CA: Genetics in Clinical Practice: New Directions in Nursing and Health Care, Sudbury, MA, Jones and Bartlett; 1998.
38. Biesecker BB, Marteau TM. The future of genetic counselling: an international perspective. Nature Genetics. 1999;22: 133-137.
39. Lynch HT, Watson P, Shaw TG, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: part I: studies of cancer in families. Cancer. 1999;S86:1629-1636.
40. Geller G, Botkin JR, Green MJ, et al. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA. 1997;277:1467-1474.
41. Offit K: Clinical Cancer Genetics Risk Counseling and Management, New York, John Wiley & Sons; 1998.
42. Lerman C, Lustbader E, Rimer B, et al.. Effects of individualized breast cancer risk counseling:a randomized clinical trial. J Nat Cancer Inst. 1995;87:286-292.
43. Schwartz MD, Lerman C, Audrain J, et al. The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med. 1998;20: 7-12.
44. Lerman C, Biesecker B, Benkendorf JL, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997;89: 148-157.
45. Lerman C, Hughes C, Lemon SJ, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol. 1998;16:1650-1654.
46. Lynch HT, Watson P, Shaw TG, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: part II: hereditary nonpolyposis colorectal carcinoma as a model. Cancer. 1999;S86: 1637-1643.